Denali Therapeutics Inc
DNLI
ISIN null / Valor 39149539
Denali Therapeutics Inc
UMushroom community rating:
About company
Denali Therapeutics Inc is a biotechnology company focused on developing therapies for neurodegenerative and lysosomal storage diseases. Leveraging their expertise in the biology of these conditions, the company's core portfolio includes programs in various stages of clinical and preclinical development aimed at addressing the underlying causes of these diseases. With a commitment to rigorous therapeutic discovery and development, Denali is dedicated to advancing molecular therapeutics that have the potential to significantly improve the lives of patients facing these challenging medical conditions.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
3151 M
Market cap (USD)
1,174,239
Daily traded volume (Shares)
20.49 / 19.93
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
John Noyb
EQUITIES OF THE SAME SECTOR
